Inspire Medical Systems, Inc. to Present at the Stifel 2022 Healthcare Conference
Inspire Medical Systems (NYSE: INSP) announced that its management team will present at the Stifel 2022 Healthcare Conference on November 16, 2022, at 2:25 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) announced that its management team will present at the Stifel 2022 Healthcare Conference on November 16, 2022, at 2:25 p.m. ET. The event will take place at the Lotte New York Palace Hotel. A live webcast of the presentation will be available and can be accessed through Inspire’s investor website, which will also host a replay for two weeks afterwards. Inspire is known for its innovative solutions for obstructive sleep apnea, including the first FDA-approved neurostimulation therapy for moderate to severe cases.
Details
News Market Reaction – INSP
The recorded move for INSP in the trading session of this news was +7.51%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022 at the Lotte New York Palace Hotel in New York, NY.
Inspire is scheduled to present at 2:25 p.m. Eastern Time. The presentation will be accessible via a live webcast at:
https://wsw.com/webcast/stifel74/register.aspx?conf=stifel74&page=insp&url=https://wsw.com/webcast/stifel74/insp/2113108
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.